Trending Articles

article thumbnail

AI-Powered Pharma: How Artificial Intelligence is Transforming Drug Development,

Pharma IQ

Discover how AI is transforming pharmaceutical development, from drug discovery to clinical trials, supply chain resilience, and personalised medicine.

Pharma 130
article thumbnail

Semaglutide shortage ends as FDA sets deadline for compounders

Pharmaceutical Technology

With Novo Nordisks blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed for now.

FDA 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma and medtech industry reacts to FDA, CDC and NIH job cuts

Pharmaceutical Technology

The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the HHS over the Valentine's Day weekend.

FDA 106
article thumbnail

Copyright’s Big Win in the First Decided US Artificial Intelligence Case

Copyright Clearance Center

The post Copyrights Big Win in the First Decided US Artificial Intelligence Case appeared first on Copyright Clearance Center.

98
article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

SMA treatment with Evrysdi 'could start prenatally'

pharmaphorum

SMA treatment with Evrysdi 'could start prenatally' Phil.

98

More Trending

article thumbnail

Kennedy’s MAHA agenda is tackling ‘conflicts of interest’ — and could take aim at FDA adcomms

PharmaVoice

Health agency job cuts and a newly-established MAHA commission leave many unanswered questions about potential reforms and impact on drug approvals.

FDA 81
article thumbnail

Anthropomorphizing AI: Dire Consequences of Mistaking Human-Like for Human Have Already Emerged

Copyright Clearance Center

The post Anthropomorphizing AI: Dire Consequences of Mistaking Human-Like for Human Have Already Emerged appeared first on Copyright Clearance Center.

96
article thumbnail

Poolbeg slumps as Hookipa merger is called off

pharmaphorum

A proposed merger of the UK's Poolbeg with Austrian biotech Hookipa has been called off after the latter abruptly withdrew from negotiations.

95
article thumbnail

Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma Med in Pivotal Testing

MedCity News

Eikon Therapeutics lead drug candidate is designed to activate toll-like receptors 7 and 8, sparking an immune response that fights cancer. Beyond this TLR7/8 agonist, the biotech is also developing PARP inhibitors that could have advantages over cancer drugs currently available from this class. The post Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma Med in Pivotal Testing appeared first on MedCity News.

Leads 95
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Rishi Sunak joins Prostate Cancer Research as an ambassador

PharmaTimes

Former UK PM advocates for national screening programme

74
article thumbnail

Pfizer shelves haemophilia gene therapy Beqvez amid low demand

Pharmaceutical Technology

Pfizer said resources will be directed to its other haemophilia gene therapy Hympavzi.

101
101
article thumbnail

AI Rights Reservation: Human Readable is Machine Readable — An Interview with Haralambos (“Babis”) Marmanis

Copyright Clearance Center

The post AI Rights Reservation: Human Readable is Machine Readable An Interview with Haralambos (Babis) Marmanis appeared first on Copyright Clearance Center.

84
article thumbnail

Ex-CDER chief Cavazzoni rejoins Pfizer as CMO

pharmaphorum

In a move that will raise eyebrows in Washington, Pfizer has hired former FDA director Patricia Cavazzoni as its new chief medical officer

FDA 95
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Future Family Guarantees ‘Baby or Your Money Back’ with New Nationwide IVF Insurance

MedCity News

Future Family launched a nationwide IVF insurance product on Wednesday. If families don’t achieve a live birth after two cycles of IVF, they can get their money back. The post Future Family Guarantees ‘Baby or Your Money Back’ with New Nationwide IVF Insurance appeared first on MedCity News.

article thumbnail

ICR researchers develop blood test to uncover how childhood tumours adapt

PharmaTimes

It is hoped that the approach will lead to more targeted treatments for childhood cancers

Leads 71
article thumbnail

J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contract

Pharmaceutical Technology

Samsung Bioepis has now allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous settlement.

99
article thumbnail

Developing High-Impact Sales Leadership in Healthcare

Healthcare Success

This week's podcast dives into successful sales leadership and is relevant to most healthcare verticals, including B2B sales in SaaS, pharmaceuticals, medical device, hospitals, etc. It also applies to high-value B2C sales, e.g., elective surgeries, orthodontics, senior care, and residential treatment centers. My guest, Chris Jennings , CEO of Chris Jennings Group , reveals the essential traits of successful healthcare sales leadership.

Sales 70
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Bayer reveals phase 3 data for improved MRI contrast agent

pharmaphorum

Bayer is close to filing a new MRI contrast agent that can reduce levels of gadolinium, which can have health and environmental consequences.

88
article thumbnail

AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal

MedCity News

FibroGen secured regulatory approvals for roxadustat in China and Europe, but the FDA rejected the drug and asked for another clinical trial. By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication. The post AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal appeared first on MedCity News.

FDA 71
article thumbnail

The Biosimilars Landscape Through the Eyes of an Economist

Pharmaceutical Commerce

James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.

article thumbnail

Transforming manufacturing and packaging at PHARMAP 2025

Pharmaceutical Technology

PHARMAP 2025 takes place on 14-15 April 2025 in Berlin, Germany.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

In FDA job cuts, experts see threat of far-reaching impact

PharmaVoice

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency commissioner Robert Califf, of the layoffs.

FDA 69
article thumbnail

Evidence builds behind Regeneron's deafness gene therapy

pharmaphorum

Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing

85
article thumbnail

Humana Taps Thyme Care for Value-Based Oncology Care

MedCity News

Some Humana members can now access Thyme Care’s cancer care services, which include 24/7 virtual care navigation. The post Humana Taps Thyme Care for Value-Based Oncology Care appeared first on MedCity News.

80
article thumbnail

Google Launches AI Co-Scientist System

PharmaTech

The AI co-scientist is a multi-agent AI system that can work as a virtual scientific collaborator.

64
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

“Digital genocide”: BMJ post alleges patient data deletion amid DEI purge

Pharmaceutical Technology

In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.

article thumbnail

FDA approves Deciphera’s Romvimza for rare tumour type

PharmaTimes

Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations

FDA 62
article thumbnail

Boehringer eyes third quarter FDA verdict for oral HER2 drug

pharmaphorum

Boehringer Ingelheim's oral HER2 inhibitor zongertinib has started an FDA review as a lung cancer treatment with a decision due in the third quarter.

FDA 85